Madrigal Pharmaceuticals Inc (MDGL)
193.33
-1.05
(-0.54%)
USD |
NASDAQ |
Apr 26, 16:00
192.00
-1.33
(-0.69%)
After-Hours: 20:00
Madrigal Pharmaceuticals 1 Year Total Returns (Daily): -37.08% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -37.08% |
April 25, 2024 | -34.28% |
April 24, 2024 | -33.09% |
April 23, 2024 | -28.04% |
April 22, 2024 | -29.66% |
April 19, 2024 | -27.68% |
April 18, 2024 | -23.18% |
April 17, 2024 | -11.00% |
April 16, 2024 | -2.84% |
April 15, 2024 | -3.51% |
April 12, 2024 | -2.05% |
April 11, 2024 | 4.78% |
April 10, 2024 | -0.27% |
April 09, 2024 | 0.71% |
April 08, 2024 | 0.43% |
April 05, 2024 | 2.66% |
April 04, 2024 | 0.37% |
April 03, 2024 | -1.46% |
April 02, 2024 | 0.92% |
April 01, 2024 | 5.56% |
March 28, 2024 | 10.90% |
March 27, 2024 | 8.59% |
March 26, 2024 | 5.52% |
March 25, 2024 | 5.52% |
March 22, 2024 | 7.42% |
Date | Value |
---|---|
March 21, 2024 | 3.92% |
March 20, 2024 | 1.20% |
March 19, 2024 | 6.01% |
March 18, 2024 | 13.02% |
March 15, 2024 | 13.22% |
March 14, 2024 | -0.41% |
March 13, 2024 | 13.36% |
March 12, 2024 | 8.70% |
March 11, 2024 | 7.66% |
March 08, 2024 | -2.06% |
March 07, 2024 | -5.87% |
March 06, 2024 | -5.00% |
March 05, 2024 | -8.74% |
March 04, 2024 | -9.45% |
March 01, 2024 | -9.87% |
February 29, 2024 | -12.84% |
February 28, 2024 | -6.19% |
February 27, 2024 | -11.71% |
February 26, 2024 | -15.80% |
February 23, 2024 | -22.97% |
February 22, 2024 | -14.84% |
February 21, 2024 | -20.96% |
February 20, 2024 | -24.29% |
February 16, 2024 | -20.98% |
February 15, 2024 | -21.27% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.97%
Minimum
Jun 06 2019
418.0%
Maximum
Jan 27 2023
30.91%
Average
-11.00%
Median
Apr 17 2024
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 96.56% |
Viking Therapeutics Inc | 280.1% |
Akero Therapeutics Inc | -55.73% |
89bio Inc | -46.74% |
Geron Corp | 55.97% |